Asymmetric Hydrosilylation of Imines
J . Org. Chem., Vol. 65, No. 3, 2000 773
HPLC analysis using a Chiralcel OJ or OD column. The major
enantiomer of each compound indicated below reflects the
major enantiomer of the reaction products with (R,R)-1 except
in the case of sertraline where (S,S)-1 was used. The H NMR
analysis of the amine products reported below is that of the
major amine product.
J ) 3.26, 19.07 Hz, 1H), 1.94-1.89 (m, 1H), 1.60-1.31 (m, 5H),
0.92 (t, J ) 6.85 Hz, 3H); 13C NMR (125 MHz, CDCl3) 206.64,
159.22, 137.01, 134.79, 127.64, 125.81, 123.72, 43.36, 38.46,
36.05, 29.94, 22.96, 14.18; IR (neat) 1711 cm-1; HRMS (EI)
m/z calcd for C13H16O1 188.1201, found 188.1205.
1
(3-n -Bu tylin d a n -1-yl)p r op yla m in e (4c). This was iso-
lated in 64% yield based on 54% conversion (Table 1, entry 5).
The ee was measured by chiral GC on a BPH column with the
corresponding trifluoroacetamide derivative (110 °C isother-
mal, 1.0 mL/min; major isomer, 90.16 min (major), 92.87 min;
minor isomer, 77.30 min (major), 80.30 min): 1H NMR (300
MHz, CDCl3) 7.37-7.32 (m, 1H), 7.23-7.16 (m, 3H), 4.18 (t, J
) 7.78 Hz, 1H), 3.01-2.90 (m, 1H), 2.77-2.63 (m, 3H), 2.05-
1.97 (m, 1H), 1.66-1.47 (m, 3H), 1.46-1.28 (m, 6H), 0.96 (t, J
) 7.33 Hz, 3H), 0.96-0.90 (m, 3H); 13C NMR (75 MHz, CDCl3)
147.10, 145.75, 127.32, 126.55, 123.71, 123.48, 62.13, 49.51,
42.33, 41.56, 34.97, 30.11, 24.00, 23.22, 14.43, 12.21; IR (neat)
3311 cm-1; HRMS (EI) m/z calcd for C16H25N1 231.1987, found
231.1982.
3-Meth yl-1-in d a n on e (3a ). This was isolated in 73% yield37
based on 49% conversion (Table 1, entry 2). The ee was
measured by chiral GC on a BPH column (90 °C isothermal,
1.0 mL/min, 25.6 min, 26.9 min (major, R)): 1H NMR (300
MHz, CDCl3) 7.73 (d, J ) 7.79 Hz, 1H), 7.62 (ddd, J ) 1.18,
7.21, 7.70 Hz, 1H), 7.51 (qd, J ) 0.92, 7.82 Hz, 1H), 7.38 (ddt,
J ) 0.62, 0.93, 7.42 Hz, 1H), 3.45 (dquint, J ) 3.50, 7.21 Hz,
1H), 2.95 (dd, J ) 7.50, 19.07 Hz, 1H), 2.29 (dd, J ) 3.42, 19.07
Hz, 1H), 1.42 (d, J ) 7.17 Hz, 3H); 13C NMR (75 MHz, CDCl3)
206.50, 160.04, 136.51, 134.87, 127.52, 125.41, 123.56, 45.60,
33.07, 21.65; IR (neat) 1710 cm-1; [R]D -6.67° (for a sample of
91.6% ee) (c 1.05, EtOH) (lit.4 [R]D 10.1° (c 3, EtOH), 100% ee
(S)).
3-ter t-Bu tyl-1-in d a n on e (3d ). This was isolated in 72%
yield based on 60% conversion (Table 1, entry 7). The ee was
measured by chiral GC on a BPH column (120 °C isothermal,
1.0 mL/min, 20.62 min, 21.94 min (major)): 1H NMR (300
MHz, CDCl3) 7.74 (d, J ) 7.47 Hz, 1H), 7.60-7.53 (m, 2H),
7.41-7.36 (m, 1H), 3.24 (dd, J ) 2.13, 7.20 Hz, 1H), 2.70 (dd,
J ) 7.27, 19.35 Hz, 1H), 2.61 (dd, J ) 1.64, 19.42 Hz, 1H),
0.94 (s, 9H); 13C NMR (125 MHz, CDCl3) 207.00, 156.49,
137.97, 133.92, 128.11, 127.74, 123.54, 49.48, 41.30, 34.71,
27.87; IR (neat) 1713 cm-1; HRMS (EI) m/z calcd for C13H16O1
188.1201, found 188.1207.
(3-ter t-Bu tylin d a n -1-yl)p r op yla m in e (4d ). This was iso-
lated in 82% yield based on 60% conversion (Table 1, entry 7).
The ee was measured by chiral GC on a BPH column with the
corresponding trifluoroacetamide derivative (130 °C isother-
mal, 1.0 mL/min; major isomer, 25.17 min (major), 27.11 min;
minor isomer, not separated): 1H NMR (300 MHz, CDCl3)
7.46-7.43 (m, 1H), 7.38-7.35 (m, 1H), 7.23-7.15 (m, 2H), 4.08
(t, J ) 7.91 Hz, 1H), 2.92 (dd, J ) 7.66 Hz, 1H), 2.79-2.69 (m,
2H), 2.48 (td, J ) 7.25, 12.23 Hz, 1H), 1.76 (br s, 1H), 1.63-
1.45 (m, 3H), 1.05 (s, 9H), 0.97 (t, J ) 7.42 Hz, 3H); 13C NMR
(125 MHz, CDCl3) 147.09, 144.78, 126.92, 126.39, 125.80,
123.92, 61.18, 53.32, 49.60, 37.47, 33.39, 28.66, 24.01, 12.16;
IR (neat) 3311 cm-1; HRMS (EI) m/z calcd for C16H25N1
231.1987, found 231.1984.
(3-Meth ylin d a n -1-yl)p r op yla m in e (4a ). This was isolated
in 69% yield based on 49% conversion (Table 1, entry 2). The
ee was measured by chiral GC on a BPH column with the
corresponding trifluoroacetamide derivative (120 °C isother-
mal, 1.0 mL/min, cis isomer, 12.6 min (major (1R,3S)), 13.5
min;, trans isomer, not separated): 1H NMR (300 MHz, CDCl3)
7.36-7.31 (m, 1H), 7.26-7.17 (m, 3H), 4.19 (dd, J ) 7.09, 8.89
Hz, 1H), 3.08-2.98 (m, 1H), 2.78-2.64 (m, 3H), 1.66-1.39 (m,
3H), 1.34 (d, J ) 6.68 Hz, 3H), 1.36-1.26 (m, 1H), 0.96 (t, J )
7.42 Hz, 3H); 13C NMR (125 MHz, CDCl3) 147.95, 145.81,
127.42, 126.52, 123.60, 123.27, 62.17, 49.54, 44.20, 36.86,
23.99, 19.89, 12.11; IR (neat) 3304 cm-1. Anal. Calcd for
C
13H19N1: C, 82.48; H, 10.12. Found: C, 82.63; H, 9.74.
3-P h en yl-1-in d a n on e (3b). This was isolated in 81% yield
based on 58% conversion (Table 1, entry 4). The ee was
measured by chiral HPLC on a OJ column (10% i-PrOH/90%
hexanes, 0.5 mL/min, 19.75 min, 25.00 min (major)): 1H NMR
(300 MHz, CDCl3) 7.81 (dd, J ) 0.50, 7.69 Hz, 1H), 7.57 (dt, J
) 1.28, 7.46 Hz, 1H), 7.42 (t, J ) 7.40 Hz, 1H), 7.34-7.22 (m,
4H), 7.14-7.11 (m, 2H), 4.58 (dd, J ) 3.84, 7.97 Hz, 1H), 3.24
(dd, J ) 7.97, 19.23 Hz, 1H), 2.70 (dd, J ) 3.85, 19.32 Hz,
1H); 13C NMR (125 MHz, CDCl3) 205.93, 158.05, 143.88,
136.99, 135.18, 129.07, 128.03, 127.78, 127.14, 127.04, 123.57,
47.01, 44.66; IR (neat) 1710 cm-1; [R]D 61.2° (for a sample of
90% ee) (c 2.50, EtOH). Anal. Calcd for C15H12O1: C, 86.51;
H, 5.81. Found: C, 86.26; H, 5.89.
(3-P h en ylin d a n -1-yl)p r op yla m in e (4b). This was isolated
in 76% yield based on 58% conversion (Table 1, entry 4). The
ee was measured by chiral GC on a BPH column with the
corresponding trifluoroacetamide derivative (140 °C for 40 min,
ramp of 0.5 °C/min to 150 °C and then isothermal for 30 min;
major isomer, 82.11 min (major), 83.37 min; minor isomer,
78.44 min (major), 80.03 min): 1H NMR (300 MHz, CDCl3)
7.42 (d, J ) 7.66 Hz, 1H), 7.35-7.15 (m, 7H), 6.91 (d, J ) 7.50
Hz, 1H), 4.31 (dd, J ) 7.25, 8.72 Hz, 1H), 4.17 (dd, J ) 7.50,
10.11 Hz, 1H), 2.93 (td, J ) 6.68, 12.23 Hz, 1H), 2.73 (t, J )
7.01 Hz, 2H), 1.79 (ddd, J ) 9.08, 10.30, 11.98 Hz, 1H), 1.64-
1.51 (m, 3H), 0.95 (t, J ) 7.48 Hz, 3H); 13C NMR (75 MHz,
CDCl3) 146.20, 145.96, 144.77, 128.67, 128.54, 127.60, 126.92,
126.62, 125.07, 123.63, 62.23, 49.38, 49.13, 45.82, 23.93, 12.09;
IR (neat) 3308 cm-1. Anal. Calcd for C18H21N1: C, 86.01; H,
8.42. Found: C, 86.34; H, 8.29.
3-Meth yl-1-in d a n on e (3a ). This was isolated in 84% yield
based on 55% conversion (Table 2, entry 2).
Meth yl(3-m eth yl-in d a n -1-yl)a m in e (6a ). This was iso-
lated in 87% yield based on 55% conversion (Table 2, entry 2).
The ee was measured by chiral GC on a GTA column with the
corresponding trifluoroacetamide derivative (110 °C isother-
mal, 1.0 mL/min; major isomer, 36.30 min (major), 38.19 min;
minor isomer, 31.66 min (major), 33.92 min): 1H NMR (300
MHz, CDCl3) 7.35-7.30 (m, 1H), 7.27-7.18 (m, 3H), 4.13 (dd,
J ) 7.51, 8.61 Hz, 1H), 3.09-3.01 (m, 1H), 2.71 (td, J ) 7.05,
12.14 Hz, 1H), 2.55 (s, 3H), 1.43 (br s, 1H), 1.35 (d, J ) 6.84
Hz, 3H), 1.37-1.24 (m, 1H); 13C NMR (75 MHz, CDCl3) 147.91,
145.13, 127.47, 126.49, 123.60, 123.25, 63.66, 43.39, 36.85,
34.04, 20.06; IR (neat) 3311 cm-1; HRMS (EI) m/z calcd for
C
11H15N1 161.1204, found 161.1201.
3-P h en yl-1-in d a n on e (3b). This was isolated in 81% yield
based on 52% conversion (Table 2, entry 6).
Meth yl(3-p h en yl-in d a n -1-yl)a m in e (6b). This was iso-
lated in 81% yield based on 52% conversion (Table 2, entry 6).
The ee was measured by chiral GC on a BPH column with the
corresponding trifluoroacetamide derivative (150 °C isother-
mal, 1.0 mL/min; major isomer, 67.15 min, 70.10 min (major);
minor isomer, 58.38 min (major), 59.72 min)): 1H NMR (300
MHz, CDCl3) 7.42 (d, J ) 7.24 Hz, 1H), 7.35-7.21 (m, 7H),
6.92 (d, J ) 7.42 Hz, 1H), 4.25 (dd, J ) 7.05, 8.71 Hz, 1H),
4.19 (dd, J ) 7.60, 10.03 Hz, 1H), 2.96 (td, J ) 7.01, 12.36 Hz,
1H), 2.56 (s, 3H), 1.77 (ddd, J ) 9.43, 10.07, 12.36 Hz, 1H),
1.58 (br s, 1H),; 13C NMR (75 MHz, CDCl3) 146.25, 145.47,
144.71, 128.68, 128.50, 127.69, 126.94, 126.64, 125.10, 123.66,
63.72, 49.07, 45.12, 33.95; IR (neat) 3319 cm-1; HRMS (EI)
m/z calcd for C16H17N1 223.1361, found 223.1356.
3-n -Bu tyl-1-in d a n on e (3c). This was isolated in 92% yield
based on 54% conversion (Table 1, entry 5). The ee was
measured by chiral GC on a BPH column with the correspond-
ing alcohols after reduction with NaBH4 (110 °C, isothermal,
1.0 mL/min; major alcohol, 95.24 min (major), 99.24 min; minor
alchol, 86.91 min (major), 91.20 min): 1H NMR (300 MHz,
CDCl3) 7.73 (d, J ) 7.66 Hz, 1H), 7.60 (dt, J ) 1.14, 7.17 Hz,
1H), 7.51 (br d, J ) 6.68 Hz, 1H), 7.37 (br t, J ) 7.58 Hz, 1H),
3.38-3.32 (m, 1H), 2.86 (dd, J ) 7.50, 19.07 Hz, 1H), 2.37 (dd,
(37) The maximum yield is 100% when the amount of (1 - %
conversion/100) × (initial mol of the starting imine substrate) is
recovered for ketone substrate and (% conversion/100) × (initial mol
of the starting imine substrate) for amine products.